1. Home
  2. TNGX vs BDJ Comparison

TNGX vs BDJ Comparison

Compare TNGX & BDJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

N/A

Current Price

$16.29

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo Blackrock Enhanced Equity Dividend Trust

BDJ

Blackrock Enhanced Equity Dividend Trust

N/A

Current Price

$9.11

Market Cap

1.6B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TNGX
BDJ
Founded
2014
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
TNGX
BDJ
Price
$16.29
$9.11
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$17.50
N/A
AVG Volume (30 Days)
3.5M
350.9K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
8.85%
EPS Growth
26.89
N/A
EPS
N/A
N/A
Revenue
$62,384,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
48.29
N/A
52 Week Low
$1.04
$7.16
52 Week High
$17.63
$9.76

Technical Indicators

Market Signals
Indicator
TNGX
BDJ
Relative Strength Index (RSI) 69.95 28.30
Support Level $10.90 $8.92
Resistance Level N/A $9.20
Average True Range (ATR) 1.16 0.11
MACD 0.44 -0.05
Stochastic Oscillator 79.65 14.39

Price Performance

Historical Comparison
TNGX
BDJ

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

About BDJ Blackrock Enhanced Equity Dividend Trust

BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.

Share on Social Networks: